Poly Medicure Limited (POLYMED) — FY26 Annual Report | 14 August 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
31st Annual General Meeting scheduled for September 5, 2026 via video conferencing
🔄 What Changed
Adoption of audited standalone and consolidated financial statements for FY2026; declaration of ₹3.50 dividend per share; re-appointment of directors Rishi Baid and Devendra Raj Mehta
🔮 What's Next
AGM will be conducted via VC/OAVM in compliance with regulatory requirements; remote e-voting period from September 2-4, 2026; shareholders must update email and mobile details for access
💡 Investor Takeaway
Shareholders must vote remotely via NSDL platform and ensure their contact details are updated to participate in the AGM.

Poly Medicure Limited announced its 31st Annual General Meeting scheduled for September 5, 2026, via video conferencing, to transact ordinary business including adoption of audited standalone and consolidated financial statements for the year ended March 31, 2026, declaration of a dividend of ₹3.50 per equity share, and re-appointment of directors Rishi Baid and Devendra Raj Mehta. The meeting will feature remote e-voting through NSDL, with specific procedural instructions for shareholders. Corporate members must submit board resolutions to attend, and physical shareholders are urged to dematerialize shares. The notice also details PAN submission requirements, email registration mandates, and proxy voting limitations.

📄 View Original Announcement (PDF)

About Poly Medicure Limited (POLYMED)

Healthcare · Healthcare Equipment & Supplies · Listed on NSE

Market Cap: ₹15,192.77 Cr P/E: 46.4

View full POLYMED stock details →

📡 Get AI alerts when POLYMED files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track POLYMED — Free

📊 More POLYMED filings

See all POLYMED filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when POLYMED files new disclosures

Track POLYMED filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track POLYMED — Free

Free account · 2 AI queries/day